跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JAYPIRCA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
JAYPIRCA
Authorized
STANDARD
JAYPIRCA
ELI LILLY CANADA INC
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
d2df7687b0bea886
Company
ELI LILLY CANADA INC
Type
Standard
Approval Details
Approval Id
d2df7687b0bea886
Drug Approval Canada Name
JAYPIRCA
Product Name
JAYPIRCA
Status
Marketed
Status Date
2025-11-28
Original Market Date
2025-11-28
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EL05 PIRTOBRUTINIB
Aig Number
0167569002
Company Name
ELI LILLY CANADA INC
Company Address
SUITE 900 Exchange Tower, 130 King Street West Toronto Ontario Canada M5X 1B1
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
d2df7687b0bea886
Type
Standard
Back to Health Canada Approvals